| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.28 | 0.05 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.35 | 0.05 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.23 | 0.05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.06 |